Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Phosphatase Inhibitor Cocktail 2 Workflow
2026-09-30
Preserve signaling information from tissue lysates, adipose samples, and cell extracts with a ready-to-use 100X multi-class phosphatase inhibitor. This workflow connects phosphorylation control to the PI3K/AKT/PPARγ findings reported in a recent type 2 diabetes study while emphasizing practical assay validation.
-
TAK-715: Designing Better p38 MAPK Assays
2026-09-30
TAK-715 is a selective p38 MAPK inhibitor for dissecting inflammatory signaling, but its greatest value depends on rigorous assay design. This guide connects biochemical potency, phospho-state biology, cytokine readouts, and practical formulation decisions.
-
Losmapimod in p38 MAPK Research Workflows
2026-09-29
Losmapimod, also called GW856553X, gives researchers a defined chemical tool for probing p38α/β signaling in inflammation, vascular biology, hypertension, and COPD models. This guide translates its pharmacology into practical assay workflows while showing how emerging dephosphorylation biology can improve experimental design without overstating what has been demonstrated.
-
SB 202190: p38 MAP Kinase Inhibitor Workflows
2026-09-29
SB 202190 enables timed, reversible inhibition of p38α/β to separate inflammatory, apoptotic, and growth signals in cell-based assays. This workflow-focused guide shows how to pair the compound with phospho-readouts, secretion assays, and pathway controls while avoiding common solubility and interpretation errors.
-
Astrocyte–Microglia Crosstalk in 2-CE Neuroinflammation
2026-09-28
The reference study proposes that astrocytes, rather than microglia, are the early cellular responders to 2-chloroethanol, an intermediate metabolite of 1,2-dichloroethane. Its main contribution is a mechanistic link between ROS-driven p38 MAPK/NF-κB and AP-1 activation in A1 astrocytes and subsequent M1-like microglial polarization through astrocyte-derived inflammatory mediators.
-
Tetraethylammonium Chloride: Interpreting K+ Blockade
2026-09-28
Tetraethylammonium chloride (TEAC) is a useful probe of potassium-channel conduction, but its effects require careful interpretation. This article connects TEAC-based experiments to β-cell channel research and shows how orthogonal readouts can strengthen mechanistic conclusions without treating distinct blockers as interchangeable.
-
SR 11302 for AP-1 Inhibitor Assays
2026-09-27
A scenario-based guide to using SR 11302 (AP-1 transcription factor inhibitor), SKU A8185, in cell-proliferation and cancer-mechanism studies. It covers model selection, formulation, interpretation, and practical supplier checks while distinguishing product information from evidence in a macrophage-signaling study.
-
CDK4, 4E-BP1, and Translation at Mitosis–G1
2026-09-26
The study examines how CDK4 regulates the translational repressor 4E-BP1 as cells move from mitosis into G1, extending evidence that CDK4 can support cap-dependent translation beyond its established role in cell-cycle control. Its findings frame translation as a cell-cycle-regulated process and suggest that CDK4 activity may complement mTORC1 in controlling 4E-BP1, with implications for interpreting translation pathways in cancer research.
-
Candida krusei Morphotypes Trigger Distinct BMEC Apoptosis
2026-09-25
Miao and colleagues found that both yeast- and hypha-phase Candida krusei induce apoptosis in bovine mammary epithelial cells, but with different dominant signaling routes: mitochondrial signaling for yeast and death ligand/receptor signaling for hyphae. Their co-culture study also implicates TLR2/ERK and JNK/ERK signaling, providing a mechanistic framework for investigating fungal mastitis and epithelial injury.
-
SP600125 for JNK Signaling: Assays and Workflows
2026-09-25
Use SP600125 to test whether JNK activity contributes to stress responses, c-Jun phosphorylation, or cytokine changes—without confusing JNK inhibition with the ERK mechanism identified in a recent nanoplastics study. This workflow pairs practical dose selection and controls with orthogonal readouts for stronger pathway interpretation.
-
DAPI (hydrochloride): Practical Staining Guide
2026-09-24
DAPI (hydrochloride) provides fluorescent DNA labeling for microscopy, chromosome staining, histochemistry, and flow-cytometric DNA-content workflows. It is suitable for fixed cells and, with concentration optimization, live cells; it is not a sequence-specific assay or a substitute for validated viability and cell-cycle controls.
-
Click-Compatible BmTyr Maps T-Cell Proteomes
2026-09-24
The study introduces a copper-dependent BmTyr proximity-labeling platform that uses an alkyne-phenol probe and click chemistry to profile subcellular proteins without relying on biotin. In primary T cells, it supports proteomic enrichment and antibody-independent validation, and it links NKAP with a previously unappreciated chromatin-associated localization.
-
TAK-715: Designing Better p38 MAPK Inhibition Assays
2026-09-23
TAK-715 is a potent p38 MAPK inhibitor for investigating p38α-dependent inflammatory signaling. This article goes beyond compound selection to show how to distinguish catalytic inhibition, activation-loop dephosphorylation, and downstream cytokine effects in a rigorous assay design.
-
Tetraethylammonium Chloride: A Causal K+ Probe
2026-09-23
Tetraethylammonium chloride (TEAC) is more than a potassium channel blocker: it is a useful causal perturbation for separating pore conduction from receptor signaling. This guide connects TEAC assay design with the landmark β-cell K+ channel study and vascular research applications.
-
JNK-IN-7 for Apoptosis and JNK Signaling Assays
2026-09-22
JNK-IN-7 provides a selective, covalent route to test whether JNK activity contributes to c-Jun phosphorylation, inflammation, and apoptosis. This workflow adapts phase-resolved Candida krusei infection findings into practical host-cell experiments while emphasizing concentration control, matched controls, and pathway-specific interpretation.